Dumocalcin Uses, Dosage, Side Effects and more
Dumocalcin is under investigation in clinical trial NCT02830854 (Molecular Dumocalcin for Cognitive Function and Performance in Elderly).
| Trade Name | Dumocalcin |
| Generic | Hydrogen |
| Hydrogen Other Names | Dihydrogen, Molecular hydrogen, Protium |
| Type | Tablet |
| Formula | H2 |
| Weight | Average: 2.016 Monoisotopic: 2.015650064 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Actavis Indonesia |
| Available Country | Indonesia |
| Last Updated: | January 7, 2025 at 1:49 am |
